GlassScriptPhysician profile
Lydia Wester
NPI 1134481740
$3,042.84
in general payments reported to CMS, 2019-2025
29 companies · $430 in 2025
The $430 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $268 · 2021: $509 · 2022: $507 · 2023: $425 · 2024: $408 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.26 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $506.83 | 2019-2025 | Liletta |
| Hologic Sales and Service, LLC | $336.89 | 2021-2025 | Acessa Provu System, Myosure Tissue Removal Device, Novasure |
| Myovant Sciences INC. | $176.64 | 2021-2022 | |
| Astellas Pharma US INC | $162.37 | 2023-2024 | Veozah, Myrbetriq |
| Organon LLC | $156.73 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $144.74 | 2023-2025 | Myfembree |
| Allergan, INC. | $138.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.35 | 2019-2023 | |
| Radius Health, INC. | $121.83 | 2019 | |
| Therapeuticsmd, INC. | $115.03 | 2019-2022 | |
| Avion Pharmaceuticals | $112.73 | 2020-2021 | |
| Exeltis, USA INC. | $111.50 | 2019-2022 | |
| Stryker Corporation | $109.50 | 2025 | Flowtriever |
| Biogen, INC. | $105.56 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $105.15 | 2019-2025 | Gardasil 9 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $102.33 | 2024-2025 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $59.26 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $45.81 | 2021-2022 | |
| Pfizer INC. | $42.27 | 2024-2025 | |
| Momentis Surgical INC. | $37.00 | 2022 | |
| Baxter Healthcare | $32.09 | 2023-2024 | Perclot, Tisseel |
| Evofem Biosciences, INC. | $31.54 | 2022 | |
| Applied Medical Resources Corporation | $30.99 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $28.63 | 2023 | Exparel, Iovera |
| Lupin INC. | $27.90 | 2019-2021 | |
| Daiichi Sankyo INC. | $22.16 | 2019 | |
| Aspira Women'S Health INC | $16.56 | 2020 | |
| Almatica Pharma LLC | $15.73 | 2025 | Loreev Xr |
| Gynesonics, INC. | $14.65 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Wester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.